Phase 3 study
Recruiting Phase 3
This trial at a glance
Where this trial is running
| Site | City | State or country | Status at this site |
|---|---|---|---|
| Royal North Shore Hospital (RNSH) | Saint Leonards | NSW | Recruiting |
| Concord Repatriation General Hospital | Sydney | NSW | Recruiting |
| Cairns Hospital | Cairns | QLD | Recruiting |
| Sunshine Coast University Private Hospital | Nambour | QLD | Suspended |
| Princess Alexandra Hospital | Woolloongabba | QLD | Suspended |
| Monash Medical Centre | Clayton | VIC | Recruiting |
| Sunshine Hospital | St Albans | VIC | Recruiting |
| Wide Bay Hospital and Health Service | Bundaberg | QLD | Withdrawn |
| Austin Hospital | Heidelberg | VIC | Recruiting |
| Liverpool Hospital | Liverpool | NSW | Recruiting |
| Fiona Stanley Hospital | Murdoch | WA | Recruiting |
| Sunshine Coast University Private Hospital | Nambour | QLD | Recruiting |
| Royal Melbourne Hospital | Parkville | VIC | Recruiting |
| Gold Coast University Hospital | Southport | QLD | Recruiting |
| Fraser Coast Renal Service, Hervey Bay Hospital | Urraween | QLD | Recruiting |
| Sydney Adventist Hospital | Wahroonga | NSW | Recruiting |
| Westmead Hospital | Westmead | NSW | Recruiting |
| Wollongong Renal Unit | Wollongong | NSW | Recruiting |
voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice
Who can join
The official eligibility criteria
Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.
Inclusion Criteria:
* Male or female at least 18 years of age.
* A diagnosis of ESKD undergoing maintenance dialysis for at least 12 weeks.
* Serum hs-CRP ≥ 2.0 mg/L.
* A diagnosis of diabetes mellitus OR ASCVD.
Exclusion Criteria:
* Subjects who participated in Part 1 (phase 2b) are not eligible to participate in Part 2 (phase 3).
* Concomitant use of systemic immunosuppressant drugs.
* Part 1 (Phase 2b) excludes subjects with a positive TB or a history of latent TB, whereas Part 2 (Phase 3) excludes active TB but allows inclusion of subjects with a latent TB and at least 4 weeks of prophylactic TB treatment.
* Abnormal LFTs.
* Any life-threatening disease expected to result in death within 12 months.
* A history of GI perforation, inflammatory bowel disease (except fully excised. ulcerative colitis), or peptic ulcer disease.
* Clinically significant active infection or history of opportunistic or invasive fungal infection.
Dates on the record
Results, publications and the official record
- No results are posted on the official record yet.
- No publications are listed on the official record yet.
- Official record and contacts on ClinicalTrials.gov – contact details for each site are kept there, and are not copied onto this page.
Sources and dates
- ClinicalTrials.gov – the record this page reformats
- ClinicalTrials.gov processing date: 21 September 2026.
- This page last checked by Voxsanity: 11 October 2026.
Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.
Not medical advice.
Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.
Letter for your doctor
A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.